Surface-treated catheters - A review

Seminars in Dialysis

Volumn 21, Issue 6, 2008, Pages 542-546

  Dwyer, Amy ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; BIOFILM; CATHETER INFECTION; CATHETERIZATION; DRUG DELIVERY SYSTEM; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; RENAL REPLACEMENT THERAPY; THROMBOSIS;

BACTEREMIA; BIOFILMS; CATHETER-RELATED INFECTIONS; CATHETERIZATION; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; RENAL DIALYSIS; THROMBOSIS;

EID: 57149139982     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00499.x     Document Type: Article

References (36)

1. Allon M : Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44 : 779 791, 2004
2. Lee T, et al. : Tunneled catheters in hemodialysis patients: reasons and subsequent outcomes. Am J Kidney Dis 46 : 501 508, 2005
3. Nori U, et al. : Comparison of low dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48 : 596 605, 2006
4. Rayner H, et al. : Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): performance against kidney disease outcomes quality initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 44 : S22 S26, 2004
5. Manerski C, Besarab A : Antimicrobial locks: putting the lock on catheter infections. Adv Chronic Kidney Dis 13 : 245 258, 2006
6. Trautner B, Darouiche R : Catheter-associated infections. Arch Intern Med 164 : 842 850, 2004
7. Vogel L, et al. : Biofilm production by Staphylococcus epidermis isolates associated with catheter-related bacteremia. Diagn Microbiol Infect Dis 26 : 139 141, 2000
8. Costerton JW, et al. : Bacterial biofilms: a common cause of persistent infections. Science 284 : 1318 1322, 1999
9. Mehall J, et al. : Fibrin sheath enhances central venous catheter infection. Crit Care Med 30 : 908 912, 2002
10. Robinson D, et al. : Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int 53 : 1792 1794, 1998
11. Sullivan R, et al. : Hemodialysis vascular catheter-related bacteremia. Am J Med Sci 334 : 458 465, 2007
12. Kovalik E, Schwab S : Treatment approaches for infected hemodialysis vascular catheters. Curr Opin Nephrol Hypertens 11 : 593 596, 2002
13. Saad T : Central venous dialysis catheters: catheter-associated infection. Semin Dial 14 : 446 451, 2001
14. Beathard G : Catheter thrombosis. Semin Dial 14 : 441 445, 2001
15. Liangos A, et al. : Long-term management of the tunneled venous catheter. Semin Dial 19 : 158 164, 2006
16. Smits J, et al. : Coagulation and haemodialysis access thrombosis. Nephrol Dial Transplant 15 : 1755 1760, 2000
17. Rooden C, et al. : Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 23 : 2655 2660, 2005
18. Timsit J, et al. : Central vein catheter-related thrombosis in intensive care patients: incidence, risk factors, and relationship with catheter-related sepsis. Chest 114 : 207 213, 1998
19. Suojanen J, et al. : Thrombus on indwelling central venous catheters: the histopathology of "fibrin sheaths". Cardiovasc Intervent Radiol 23 : 194 197, 2000
20. Forauer A, Theoharis C : Histologic changes in the human vein wall adjacent to indwelling central venous catheters. J Vasc Interv Radiol 14 : 1163 1168, 2003
21. Falgas M, et al. : Rifampin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 59 : 359 369, 2007
22. Walder B, et al. : Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol 23 : 748 756, 2002
23. Darouche R, et al. : A comparison of two antimicrobial impregnated central venous catheters. N Engl J Med 341 : 1 8, 1999
24. Centers for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Rep 51 : 1 26, 2002
25. Halton K, Graves N : Economics of preventing catheter-related bloodstream infections. Emerg Infect Dis 13 : 815 823, 2007
26. Beathard G : Catheter management protocol for catheter-related bacteremia prophylaxis. Semin Dial 16 : 403 405, 2003
27. Chatzinikolaou I, et al. : Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 115 : 352 357, 2003
28. Rupp M, et al. : Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections. Ann Intern Med 143 : 570 581, 2005
29. Trerotola S, et al. : Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection - a randomized study. Radiology 207 : 491 496, 1998
30. Bambauer R, et al. : Long-term catheters for apheresis and dialysis with surface treatment with infection resistance and low thrombogenicity. Ther Apher Dial 7 : 225 231, 2003
31. Alderman R, Sugarbaker P : Prospective nonrandomized trial of silver impregnated cuff central lines. Int Surg 90 : 219 222, 2005
32. Lumsden A : A unique combination technology of ePTFE and proprietary end-point covalent bonding of heparin for lower extremity revascularization: the GORE PROPATEN vascular graft. Vasc Dis Manag 4 (Suppl. B 11B 14B, 2007
33. ®. Reading, UK : BioInteractions Ltd., 2000
34. Spire Biomedical : In Vitro and Animal Data on File, Sheep Study Duration: 25-30 days. Medical Device Evaluation Center, Salt Lake City, UT : Spire Biomedical, 2005
35. Sandhu S, Luthra A : Developments in biointeracting materials for medical application. Med Device Manuf Technol 1 : 1 4, 2004
36. ® Biosurface. Available at http://www.medtronic. com/cardsurgery/arrested-heart/biopassive.html, accessed April 29, 2008